Article
The GATA1-HS2 enhancer allows persistent and position-independent expression of a β-globin transgene.
PloS one - 1 Jan 2011
Miccio Annarita, Poletti Valentina, Tiboni Francesca, Rossi Claudia, Antonelli Antonella, Mavilio Fulvio, Ferrari Giuliana
Abstract excerpt
Gene therapy of genetic diseases requires persistent and position-independent expression of a therapeutic transgene. Transcriptional enhancers binding chromatin-remodeling and modifying complexes may play a role in shielding transgenes from repressive chromatin effects. We tested the activity of the HS2 enhancer of the GATA1 gene in protecting the expression of a β-globin minigene delivered by a lentiviral vector...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
